Home > Insider Trading > Filing (0000904454-15-000676)

Filing Details

Accession Number:: 0000904454-15-000676
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-04 18:36:41
Reporting Period:: 2015-11-02

Filing Date:: 2015-11-04
Accepted Time:: 2015-11-04 18:36:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369786	Sagent Pharmaceuticals Inc.	SGNT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1400245	Vivo Ventures Vi Affiilates Fund, L.p.	575 H:igh Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No
1469473	Vivo Ventures Fund Vi, L.p.	575 High Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No
1469547	Vivo Ventures Vi, Llc	575 High Street, Suite 201 Palo Alto CA 94301	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-11-02	92,843	$16.87	4,057,543	No	4	S	Indirect	See footnote (3)
Common Stock	Disposition	2015-11-02	680	$16.87	29,725	No	4	S	Indirect	See footnote (4)
Common Stock	Disposition	2015-11-03	66,793	$16.32	3,990,750	No	4	S	Indirect	See footnote (5)
Common Stock	Disposition	2015-11-03	490	$16.32	29,235	No	4	S	Indirect	See footnote (6)
Common Stock	Disposition	2015-11-04	532,119	$15.45	3,458,631	No	4	S	Indirect	See footnote (7)
Common Stock	Disposition	2015-11-04	3,898	$15.45	25,337	No	4	S	Indirect	See footnote (8)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote (3)
No	4	S	Indirect	See footnote (4)
No	4	S	Indirect	See footnote (5)
No	4	S	Indirect	See footnote (6)
No	4	S	Indirect	See footnote (7)
No	4	S	Indirect	See footnote (8)

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.59 to $17.14 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $17.69 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Includes 4,057,543 shares held of record by Vivo Ventures Fund VI, L.P. ("Fund VI"). Vivo Ventures VI, LLC, the sole general partner of Fund VI, may be deemed to be the beneficial owner of the shares held by Fund VI. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by Fund VI, except to the extent of its pecuniary interest therein.
Includes 29,725 shares held of record by Vivo Ventures VI Affiliates Fund, L.P. ("VI Affiliates Fund"). Vivo Ventures VI, LLC, the sole general partner of VI Affiliates Fund, may be deemed to be the beneficial owner of the shares held by VI Affiliates Fund. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by VI Affiliates Fund, except to the extent of its pecuniary interest therein.
Includes 3,990,750 shares held of record by Vivo Ventures Fund VI, L.P. ("Fund VI"). Vivo Ventures VI, LLC, the sole general partner of Fund VI, may be deemed to be the beneficial owner of the shares held by Fund VI. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by Fund VI, except to the extent of its pecuniary interest therein.
Includes 29,235 shares held of record by Vivo Ventures VI Affiliates Fund, L.P. ("VI Affiliates Fund"). Vivo Ventures VI, LLC, the sole general partner of VI Affiliates Fund, may be deemed to be the beneficial owner of the shares held by VI Affiliates Fund. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by VI Affiliates Fund, except to the extent of its pecuniary interest therein.
Includes 3,458,631shares held of record by Vivo Ventures Fund VI, L.P. ("Fund VI"). Vivo Ventures VI, LLC, the sole general partner of Fund VI, may be deemed to be the beneficial owner of the shares held by Fund VI. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by Fund VI, except to the extent of its pecuniary interest therein.
Includes 25,337 shares held of record by Vivo Ventures VI Affiliates Fund, L.P. ("VI Affiliates Fund"). Vivo Ventures VI, LLC, the sole general partner of VI Affiliates Fund, may be deemed to be the beneficial owner of the shares held by VI Affiliates Fund. Vivo Ventures VI, LLC hereby disclaims any beneficial ownership of any shares directly held by VI Affiliates Fund, except to the extent of its pecuniary interest therein.